Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$44,148,376
+$39,095,325 QoQ
Shares Held
5,274,597
+840.5% QoQ
Ownership
2.35%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#10
of 323 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. ADMA ranks #28 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in ADMA
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,148,376 | 5,274,597 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,053,051 | 560,827 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $10,162,470 | 557,153 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,877,396 | 332,701 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $15,160,972 | 832,563 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $30,266,455 | 1,525,527 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $52,591,760 | 3,066,575 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $105,229,258 | 5,264,095 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $76,298,099 | 6,824,517 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $35,519,338 | 5,381,718 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $29,441,258 | 6,513,553 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $27,106,660 | 7,571,693 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $30,161,383 | 8,173,817 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $27,180,306 | 8,211,573 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $33,012,626 | 8,508,409 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $14,200,423 | 5,843,796 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $9,568,135 | 4,832,392 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,481,186 | 1,902,288 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $125,922 | 89,307 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $338,707 | 211,692 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $23,971 | 10,030 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||